Guidelines for the management of hypertension and target organ damage

Journal of Hypertension

Volumn 31, Issue 12, 2013, Pages 2463-2464

  Zakopoulos, Nikolaos ^a   Manios, Efstathios ^a   Moulopoulos, Spyridon ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); HYPERTENSION; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TARGET ORGAN;

FEMALE; HUMANS; HYPERTENSION; MALE;

EID: 84888100660     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000003     Document Type: Letter

References (5)

1. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
2. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-153.
3. Rothwell P. Limitations of the usual blood pressure hypothesis and importance of variability, instability and episodic hypertension. Lancet 2010; 375:938-948.
4. Zakopoulos N, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. J Hypertens 2005; 45:505-512.
5. Mancia G. Defining blood pressure goals: is it enough to manage total cardiovascular risk? J Hypertens 2009; 27:S3-S8.